C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease

Published:2015-05 Issue:5 Volume:64 Page:597-610
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Li Ling,Chen Lijia,Zang Jing,Tang Xi,Liu Yan,Zhang Jie,Bai Lin,Yin Qinghua,Lu Yanrong,Cheng Jingqiu,Fu Ping,Liu Fang

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference36 articles.

1. VEGF and angiopoietins in diabetic glomerulopathy: how far for a new treatment?;Dei Cas;Metabolism,2012

2. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition;Zeisberg;J Am Soc Nephrol,2008

3. Myofibroblasts, regeneration or renal fibrosis—is there a decisive hint?;Lindquist;Nephrol Dial Transplant,2013

4. Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease;He;Clin Exp Nephrol,2013

5. Renal fibroblasts and myofibroblasts in chronic kidney disease;Strutz;J Am Soc Nephrol,2006

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement anaphylatoxins: Potential therapeutic target for diabetic kidney disease;Diabetic Medicine;2024-08-27

2. Pathophysiology in Brain Arteriovenous Malformations: Focus on Endothelial Dysfunctions and Endothelial-to-Mesenchymal Transition;Biomedicines;2024-08-07

3. Alantolactone alleviates epithelial-mesenchymal transition by regulating the TGF-β/STAT3 signaling pathway in renal fibrosis;Heliyon;2024-08

4. Complement C3a/C3aR and C5a/C5aR deposits accelerate the progression of advanced IgA nephropathy to end-stage renal disease;Clinical and Experimental Medicine;2024-06-29

5. Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis;Vascular Pharmacology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3